Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
08 February 2024 | Story Lunga Luthuli | Photo SUPPLIED
Student Campus Tour
The UFS Division of Student Affairs is helping first-time students get their bearings by offering campus tours on the Bloemfontein, South, and Qwaqwa campuses.

The University of the Free State’s (UFS’s) Division of Student Affairs is ready to welcome 2024’s first-time entering students (FTENS) for the new academic year with an engaging campus tour. 

These tours will take place on the Bloemfontein and South Campuses from 5 to 8 February starting at 12:00, and on the Qwaqwa Campus from 12 to 15 February, with one tour daily, from 14:00. Students must note that the 5 to 8 February schedule aligns with specific colleges each day, which means you should attend on the day specified below for students from your college.

The comprehensive tour route covers vital campus locations, including Protection Services, the Administration buildings, examination venues, Kovsie Health, Student Counselling and Development, Arts and Culture, Callie Human, HMS, Main Building, and many more. The itinerary helps students become familiar with significant facilities on the three UFS campuses.

The Division of Student Affairs aims to make the campus tours even more inclusive by allowing commuter students and late registrants to join a later group of tours, on 12 and 14 February on the Bloemfontein Campus.

Campus Tours

Tour guide

ROUTE: 


Main locations: 

Bloemfontein Campus:
Meet at the Kovsie Village (i.e. the tent next to the EXR registration venue)-> Protection Services (Stopping Point) -> George du Toit -> EXR -> Kovsie Health; SCD; Food Environment Office; Arts and Culture -> Callie Human -> HMS -> Main Building -> ECLA Lab -> Vishuis -> 24-hour study labs -> Stabilis -> Bridge (Bank; Van Schaik) -> FGG -> EBW -> Landbou; Visitors Gate-> Kopanong; Genmin Lectorium -> Computer Lab -> Mabaleng Auditorium -> Winkie Direko (Fundza Offices) -> Ned Education Building -> Modlec; Konica Minolta -> Library (organise in faculty).



South Campus Tour:

Dates: 6 and 8 February 2024
Time: 12:00 
Starting point: Amphitheatre (Outside the cafeteria)

Qwaqwa Campus Tour:

Date: 12 February 2024             
Time: 14:00 (Faculty of Economic and Management Sciences)
Assembly point: Amphitheatre

Date: 13 February 2024             
First time slot: 14:00 (Faculty of Natural and Agricultural Sciences)
Assembly point: Amphitheatre

Date: 14 February 2024
First time slot: 14:00 (Faculty of Education)
Assembly point: Amphitheatre

Date: 15 February 2024             
First time slot: 14:00 (Faculty of the Humanities)
Assembly point: Amphitheatre

Qwaqwa Off Campus Tour

Date: 18 February 2024
Time: 08:00
Assembly point: Amphitheatre

To register for the campus tours, please click here

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept